Skin acts as the first line of defense against pathogens and other harmful material from outside the body. Yet this barrier also excludes some beneficial drugs that could treat skin diseases. Now, researchers have taken the first steps in developing a chemotherapy for melanoma that can be “painted” directly on the skin, rather than injected or taken orally.
They report their results in ACS Nano.
According to the Skin Cancer Foundation, melanoma is the deadliest form of cancer because of its tendency to spread, or metastasize, from the skin to other parts of the body. Common treatments include surgery, radiation therapy and intravenous chemotherapy, but these can cause pain or unpleasant side effects. If scientists could find a way to administer chemotherapy through the skin, they could target the treatment directly to the tumor site and possibly avoid side effects. Bingfang He, Ran Mo and colleagues wanted to develop a gel that patients themselves could apply to a skin tumor. But first they had to figure out how to get the therapy to penetrate deep within the skin.
For this purpose, the researchers assembled nanoparticles called “transfersomes,” which consist of a phospholipid bilayer and surfactants that encapsulate drugs or other molecules — in this case, the chemotherapy drug paclitaxel. The surfactants made the particles more deformable so that they could better infiltrate the skin; these compounds also affected the lipid matrix of the skin to help the particles more easily pass. The researchers added a peptide to the surface of the transfersome to further help the particle penetrate the skin, as well as enter tumor cells. To increase the time that the transfersomes persisted on skin, the researchers embedded the nanoparticles into a hydrogel. Then, they painted the gel on tumors of melanoma-bearing mice once a day, in combination with intravenous administration of paclitaxel every other day. After 12 days, the tumors of these mice were about half the size of tumors in mice treated with intravenous paclitaxel alone, suggesting that the transfersome gel helped slow tumor growth.
Learn more: Paintable chemotherapy shrinks skin tumors in mice
The Latest on: Melanoma
[google_news title=”” keyword=”melanoma” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Melanoma
- IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meetingon April 24, 2024 at 2:11 pm
IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win ® platform, today announced the acceptance of ...
- Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meetingon April 24, 2024 at 1:17 pm
Iovance will host an event on the evening of Friday, May 31, 2024 to summarize the data highlights at ASCO. The live and archived event webcast will be available in the Investors section of the ...
- IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Studyon April 24, 2024 at 7:05 am
IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that interim results from the ...
- Hometown Hero: Mary Colette Coyne inspired to fight skin cancer after daughter's deathon April 24, 2024 at 5:00 am
One campaign member who praised Coyne’s efforts is Corey Eisner, whose wife, Mary Ann, died after what he called “a fierce battle” with melanoma more than 20 years ago. Eisner, of Levittown, recalled ...
- Student sun safety art contest offers big prizeson April 23, 2024 at 8:49 pm
Getting the word out about skin safety in the Sunshine State is no easy task. However, the RDK Melanoma Foundation is reaching out to kids to coach the youngest members of the public.
- Exploring geography-based health disparities in Michiganon April 23, 2024 at 8:12 pm
The Michigan Daily spoke to researchers from three different studies that examined disparities in care in different geographic areas of MI.
- Free skin cancer screening coming up at Arnot Healthon April 23, 2024 at 1:08 pm
Arnot Health is offering free skin cancer screenings to the public on Melanoma Monday. Patients who do not currently have a dermatologist are invited to the Falck Cancer Center, located at 600 Roe Ave ...
- Evidence Lacking on Best Surveillance Strategies for Melanomaon April 23, 2024 at 7:30 am
Results of a systematic review suggest more data are needed to identify optimal surveillance strategies for patients with melanoma.
- Rising melanoma cases in Finland prompt calls for enhanced sun protectionon April 23, 2024 at 6:58 am
Melanoma incidence in Finland is on the rise, particularly among the younger population who often underestimate the long-term health risks posed by sun exposure. Despite increasing awareness about the ...
via Bing News